small interfering RNA). Based on chromatin immunoprecipitation assay, this inhibition was mediated by direct HDAC11 interaction with the PAI-1 gene (Serpine1) promoter. The I/R-induced release of HDAC11 from PAI-1 promoter then led to increased histone H3 acetylation. This effect was observed only in males without orchiectomy but not in orchiectomized males or intact or ovariectomized females. This observation, coupled with the fact that DHT reversed the effect of orchiectomy on I/R-induced decreased HDAC11 expression, pointed to a testosterone-HDAC11-PAI-1 axis as a likely pathway regulating gender-induced differences in I/R-induced renal injury (Fig. 1) .
Gender is an important regulator of susceptibility to AKI in a wide range of renal insults (reviewed in Ref.
3). These gender-induced differences have been attributed to biological effects of male and female sex hormones. While some of these differences may be explained by testosterone-enhanced susceptibility to endoplasmic reticulum stress (2), additional specific mechanisms underlying the sex hormone effects in AKI have remained elusive. The current study by Kim et al. (4) points to testosterone-induced HDAC11-regulated histone H3 acetylation as a key mechanism responsible for gender-related susceptibility to AKI.
This new concept offers a novel avenue for development of gender-based therapeutic strategies, an important component of emerging personalized medical care (7). While such strategies hold potential for reducing adverse outcomes in clinical care (e.g., in males with high risk of AKI), first it is necessary to confirm that the above concept is not murine specific but can be also applied to humans and other mammals (e.g., unlike the outcome of the current study on mice, testosterone protected kidneys from I/R-induced AKI in rats; Ref. 6 ). In addition, the findings in the paper also raise questions of potentially unpredictable adverse effect of non-selective HDAC inhibitors in AKI. Unfortunately, specific HDAC11 activity-enhancing therapeutics have not been described; their development may hasten potential translation of this discovery to clinical care.
